New approaches to pharmacotherapy in patients with stable chronic obstructive pulmonary disease

Medicine and Dentistry

• Combination Therapy 100%
• Patient 75%
• Diseases 50%
• Drug Therapy 50%
• Chronic Obstructive Pulmonary Disease 50%
• Development 50%
• Biological Product 25%
• Antibiotics 25%
• Antioxidant 25%
• Pathophysiology 25%
• Cause of Death 25%
• Regeneration 25%
• Bronchodilating Agent 25%
• Antiinflammatory Agent 25%
• Nicotine Withdrawal 25%
• Muscarinic Antagonist 25%
• Oxygen Therapy 25%
• Sympathomimetic Drug 25%
• Comprehension 25%
• Inpatient 25%
• Lung 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 50%
• Chronic Obstructive Lung Disease 50%
• Biological Product 25%
• Bronchodilating Agent 25%
• Antibiotic Agent 25%
• Antiinflammatory Agent 25%
• Antioxidant 25%
• Muscarinic Receptor Blocking Agent 25%
• Adrenergic Receptor Stimulating Agent 25%
• Statin (Protein) 25%
• Pathophysiology 25%
• Cause of Death 25%
• Drug Development 25%